Misplaced Pages

Amlodipine/atorvastatin

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Caduet) Cholesterol and blood pressure medication

Pharmaceutical compound
Amlodipine/atorvastatin
Combination of
AmlodipineCalcium channel blocker
AtorvastatinStatin
Clinical data
Trade namesCaduet, Envacar, others
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • AU: D
  • Contraindicated
Routes of
administration		By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: ℞-only
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
CompTox Dashboard (EPA)
  (verify)

Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker.

Society and culture

Brand names

Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines.

In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer.

References

  1. Curran MP (2010). "Amlodipine/Atorvastatin". Drugs. 70 (2). Springer Science+Business Media: 191–213. doi:10.2165/11204420-000000000-00000. ISSN 0012-6667. PMID 20108992. S2CID 209144335.
  2. Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.
  3. "Caduet - Drugs.com". Archived from the original on 19 June 2014.
  4. "Envacar - Drugs.com". Archived from the original on 20 June 2014.
  5. "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.
  6. "Caduet". Pfizer. Retrieved 17 June 2024.
  7. "Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.
Lipid-lowering agents (C10)
GI tract
Cholesterol absorption inhibitors, NPC1L1
Bile acid sequestrants/resins (LDL)
Liver
Statins (HMG-CoA reductase, LDL)
Niacin and derivatives (HDL and LDL)
MTTP inhibitors (VLDL)
ATP citrate lyase inhibitors (LDL)
Thyromimetics (VLDL)
Blood vessels
PPAR agonists (LDL)
Fibrates
Others
CETP inhibitors (HDL)
PCSK9 inhibitors (LDL)
ANGPTL3 inhibitors (LDL/HDL)
Combinations
Other
Portal:


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: